Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker FATE
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Jun 2, 2026 | 12642852 Genomic engineering of pluripotent cells | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| May 5, 2026 | 12618049 Reprogramming methods and cell culture platforms | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Mar 17, 2026 | D1118968 Vial rack | FATE Fate Therapeutics, Inc. | design | Google Patents ↗ |
| Oct 7, 2025 | 12435123 Immunotherapies using enhanced iPSC derived effector cells | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Sep 23, 2025 | 12419870 Compositions and methods for immune cell modulation in adoptive immun… | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Sep 16, 2025 | 12415989 Cell culture platform for single cell sorting and enhanced reprogramm… | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Sep 9, 2025 | 12410403 Methods and compositions for inducing hematopoietic cell differentiat… | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Aug 26, 2025 | 12398373 Enhanced immune effector cells and use thereof | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Aug 12, 2025 | 12385012 Methods and compositions for inducing hematopoietic cell differentiat… | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Jul 8, 2025 | 12351831 Platform for the induction and maintenance of ground state pluripoten… | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Apr 22, 2025 | 12281329 Compositions and methods for immune cell modulation in adoptive immun… | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Apr 15, 2025 | 12275955 Combining iPSC derived effector cell types for immunotherapy use | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Apr 1, 2025 | 12264322 Minimal volume reprogramming of mononuclear cells | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Mar 11, 2025 | 12247226 Cellular reprogramming using temporal and transient plasmid vector ex… | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Jan 21, 2025 | 12203098 Cells having solid tumor targeting backbone and use thereof | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Dec 24, 2024 | 12173274 Enhanced immune effector cells and use thereof | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
| Oct 22, 2024 | 12122846 Chimeric antigen receptor for tumor targeting | FATE Fate Therapeutics, Inc. | utility | Google Patents ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:28 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances